Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.

International journal of molecular sciences - 20 Feb 2021

Altschuler Joshua, Stockert Jennifer A, Kyprianou Natasha

Abstract excerpt

Prostate cancer (PCa) mortality remains a significant public health problem, as advanced disease has poor survivability due to the development of resistance in response to both standard and novel therapeutic interventions. Therapeutic resistance is a multifaceted problem involving the interplay of a number of biological mechanisms including genetic, signaling, and phenotypic alterations, compounded by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial-Mesenchymal Transition

Share to Neoplasm Metastasis

Share to Phenotype

Share to Prostate Cancer Treatment and Research

Share to Prostatic Neoplasms

Share to RNA, Untranslated

Source

Open in PubMed Open full text

Identifiers

PMID: 33672595
DOI: 10.3390/ijms22042100
PMCID: PMC7924036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.PMID 33672595Read ↗

Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.Semantic proximity Read ↗

Mechanisms of resistance to androgen deprivation therapy in prostate cancer.Semantic proximity Read ↗

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approachesSemantic proximity Read ↗

Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAsSemantic proximity Read ↗

Interplay between the androgen receptor signaling axis and microRNAs in prostate cancerSemantic proximity Read ↗

Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancerSemantic proximity Read ↗

Therapeutic Potential of miRNAs in Prostate Cancer: From Mechanisms to Targeted Therapy and Clinical ApplicationsSemantic proximity Read ↗

Epigenetics-Based Diagnostic and Therapeutic Strategies: Shifting the Paradigm in Prostate CancerSemantic proximity Read ↗

Targeting the androgen receptor and overcoming resistance in prostate cancerSemantic proximity Read ↗

Emergent dynamics of underlying regulatory network links EMT and androgen receptor-dependent resistance in prostate cancerSemantic proximity Read ↗

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical ApplicationsSemantic proximity Read ↗

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.